Human hepatitis B immunoglobulin (Sanquin)
人乙型肝炎免疫球蛋白 (Sanquin)
Report date: 2022/01/14 13:23:58
Base Information
Drug NameHuman hepatitis B immunoglobulin (Sanquin)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved Indications
Approved Indications in ChinaN/A
Original Approved Country/Territory
Original Approved Date1997/02/01
Country/Territory
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesSanquin Plasma Products Bv
China Registration ClassN/A
Develop Information
Active CompaniesSanquin Plasma Products Bv
Inactive CompaniesProthya Biosolutions Netherlands BV
Active Indications
Inactive IndicationsN/A
Other Information
ATC Code
Related LinksN/A